MITOTANE for Metastatic neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where MITOTANE was used for Metastatic neoplasm.
Most Reported Side Effects for MITOTANE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 210 | 20.8% | 6 | 37 |
| Fatigue | 205 | 20.3% | 10 | 42 |
| Off label use | 154 | 15.2% | 11 | 25 |
| Diarrhoea | 123 | 12.2% | 3 | 22 |
| Vomiting | 97 | 9.6% | 6 | 29 |
| Drug ineffective | 86 | 8.5% | 10 | 25 |
| Decreased appetite | 77 | 7.6% | 5 | 25 |
| Adrenal insufficiency | 76 | 7.5% | 2 | 18 |
| Dizziness | 76 | 7.5% | 2 | 12 |
| Asthenia | 70 | 6.9% | 3 | 24 |
| Malignant neoplasm progression | 61 | 6.0% | 15 | 14 |
| Neutropenia | 48 | 4.8% | 4 | 7 |
| Febrile neutropenia | 42 | 4.2% | 2 | 4 |
| Headache | 42 | 4.2% | 1 | 11 |
| Anaemia | 41 | 4.1% | 2 | 12 |
Other Indications for MITOTANE
Adrenocortical carcinoma (461)
Adrenal gland cancer (250)
Product used for unknown indication (88)
Metastases to lung (25)
Metastases to liver (23)
Cushing's syndrome (22)
Adjuvant therapy (18)
Chemotherapy (10)
Neoplasm malignant (10)
Adrenal gland cancer metastatic (9)
Other Drugs Used for Metastatic neoplasm
ATEZOLIZUMAB (130)
CARBOPLATIN (118)
PEMBROLIZUMAB (117)
PALBOCICLIB (116)
CISPLATIN (113)
CAPECITABINE (105)
BEVACIZUMAB (98)
NIVOLUMAB (88)
PACLITAXEL (88)
TRASTUZUMAB (88)